204 related articles for article (PubMed ID: 29395611)
1. Adjunctive raloxifene for postmenopausal women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zhu XM; Zheng W; Li XH; Cai DB; Yang XH; Ungvari GS; Ng CH; Wang XP; Kulkarni J; Grigg J; Ning YP; Xiang YT
Schizophr Res; 2018 Jul; 197():288-293. PubMed ID: 29395611
[TBL] [Abstract][Full Text] [Related]
2. Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Usall J; Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; Parés GG; Cuadras D; Franco J; Miquel E; Reyes JC; Roca M;
Schizophr Bull; 2016 Mar; 42(2):309-17. PubMed ID: 26591005
[TBL] [Abstract][Full Text] [Related]
3. Estradiol and raloxifene as adjunctive treatment for women with schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Li Z; Wang Y; Wang Z; Kong L; Liu L; Li L; Tang Y
Acta Psychiatr Scand; 2023 Apr; 147(4):360-372. PubMed ID: 36585771
[TBL] [Abstract][Full Text] [Related]
4. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a meta-analysis of randomized controlled trials.
Wang Q; Dong X; Wang Y; Li X
Arch Womens Ment Health; 2018 Feb; 21(1):31-41. PubMed ID: 28849318
[TBL] [Abstract][Full Text] [Related]
5. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Huerta-Ramos E; Labad J; Cobo J; Núñez C; Creus M; García-Parés G; Cuadras D; Franco J; Miquel E; Reyes JC; Marcó-García S; ; Usall J
Eur Arch Psychiatry Clin Neurosci; 2020 Sep; 270(6):729-737. PubMed ID: 31728631
[TBL] [Abstract][Full Text] [Related]
6. Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial.
Kianimehr G; Fatehi F; Hashempoor S; Khodaei-Ardakani MR; Rezaei F; Nazari A; Kashani L; Akhondzadeh S
Daru; 2014 Jul; 22(1):55. PubMed ID: 25012765
[TBL] [Abstract][Full Text] [Related]
7. Raloxifene as an adjunctive treatment for postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
Usall J; Huerta-Ramos E; Iniesta R; Cobo J; Araya S; Roca M; Serrano-Blanco A; Teba F; Ochoa S
J Clin Psychiatry; 2011 Nov; 72(11):1552-7. PubMed ID: 21903021
[TBL] [Abstract][Full Text] [Related]
8. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia.
Kulkarni J; Gurvich C; Lee SJ; Gilbert H; Gavrilidis E; de Castella A; Berk M; Dodd S; Fitzgerald PB; Davis SR
Psychoneuroendocrinology; 2010 Sep; 35(8):1142-7. PubMed ID: 20171784
[TBL] [Abstract][Full Text] [Related]
9. Effect of Adjunctive Raloxifene Therapy on Severity of Refractory Schizophrenia in Women: A Randomized Clinical Trial.
Kulkarni J; Gavrilidis E; Gwini SM; Worsley R; Grigg J; Warren A; Gurvich C; Gilbert H; Berk M; Davis SR
JAMA Psychiatry; 2016 Sep; 73(9):947-54. PubMed ID: 27438995
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive intranasal oxytocin for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Zhu XM; Zhang QE; Yang XH; Cai DB; Li L; Li XB; Ng CH; Ungvari GS; Ning YP; Xiang YT
Schizophr Res; 2019 Apr; 206():13-20. PubMed ID: 30573406
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive celecoxib for schizophrenia: A meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Cai DB; Yang XH; Ungvari GS; Ng CH; Müller N; Ning YP; Xiang YT
J Psychiatr Res; 2017 Sep; 92():139-146. PubMed ID: 28445800
[TBL] [Abstract][Full Text] [Related]
12. Specificity proteins 1 and 4 in peripheral blood mononuclear cells in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Vila È; Huerta-Ramos E; Núñez C; Usall J; Ramos B
Eur Arch Psychiatry Clin Neurosci; 2019 Dec; 269(8):941-948. PubMed ID: 30167782
[TBL] [Abstract][Full Text] [Related]
13. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.
Labad J; Martorell L; Huerta-Ramos E; Cobo J; Vilella E; Rubio-Abadal E; Garcia-Pares G; Creus M; Núñez C; Ortega L; Miquel E; ; Usall J
Eur Neuropsychopharmacol; 2016 Oct; 26(10):1683-9. PubMed ID: 27546373
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive memantine for schizophrenia: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Zheng W; Li XH; Yang XH; Cai DB; Ungvari GS; Ng CH; Wang SB; Wang YY; Ning YP; Xiang YT
Psychol Med; 2018 Jan; 48(1):72-81. PubMed ID: 28528597
[TBL] [Abstract][Full Text] [Related]
16. Amantadine for Antipsychotic-Related Weight Gain: Meta-Analysis of Randomized Placebo-Controlled Trials.
Zheng W; Wang S; Ungvari GS; Ng CH; Yang XH; Gu YH; Li M; Xiang YQ; Xiang YT
J Clin Psychopharmacol; 2017 Jun; 37(3):341-346. PubMed ID: 28383359
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive ondansetron for schizophrenia: A systematic review and meta-analysis of randomized controlled trials.
Zheng W; Cai DB; Zhang QE; He J; Zhong LY; Sim K; Ungvari GS; Ning YP; Xiang YT
J Psychiatr Res; 2019 Jun; 113():27-33. PubMed ID: 30878789
[TBL] [Abstract][Full Text] [Related]
18. Adjunctive Reboxetine for Schizophrenia: Meta-analysis of Randomized Double-blind, Placebo-controlled Trials.
Zheng W; Li XB; Shi ZM; Yang XH; Cai DB; Ng CH; Ungvari GS; Liu WJ; Wu YJ; Wang YY; Ning YP; Xiang YT
Pharmacopsychiatry; 2020 Jan; 53(1):5-13. PubMed ID: 31207653
[TBL] [Abstract][Full Text] [Related]
19. Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a double-blind, randomized, placebo-controlled trial.
Huerta-Ramos E; Iniesta R; Ochoa S; Cobo J; Miquel E; Roca M; Serrano-Blanco A; Teba F; Usall J
Eur Neuropsychopharmacol; 2014 Feb; 24(2):223-31. PubMed ID: 24342775
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adjunctive topiramate for schizophrenia: a meta-analysis of randomized controlled trials.
Zheng W; Xiang YT; Xiang YQ; Li XB; Ungvari GS; Chiu HF; Correll CU
Acta Psychiatr Scand; 2016 Nov; 134(5):385-398. PubMed ID: 27585549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
